In a small trial of 14 patients, a CRISPR gene editing therapy improved vision among 11 participants, according to research led by a Mass General Brigham clinician. The phase 1/2 trial, sponsored by ...
Add Yahoo as a preferred source to see more of our stories on Google. For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the ...
FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...
Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...
Please provide your email address to receive an email when new articles are posted on . MCO-010, a mutation-agnostic gene therapy, demonstrated vision improvement in retinitis pigmentosa. Nanoscope ...
CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...
Randomized trials of two FDA-approved intravitreal complement inhibitor injections showed that they slowed the progression of geographic atrophy, but failed to demonstrate functional benefits at 24 ...
CNN — (CNN) — For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results